Galera Therapeutics, Inc. (GRTX) Financials
GRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 6.2 million | 1.1 million |
| Dec. 31, 2025 | 7.2 million | 645000 |
| Sept. 30, 2025 | 5.0 million | 151.6 million |
| June 30, 2025 | 6.0 million | 154.0 million |
GRTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | -2.2 million | 92000 |
| Sept. 30, 2025 | -757000 | 91000 |
| June 30, 2025 | 2.2 million | 90000 |
GRTX Net Income
No data available :(
GRTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 5.5 million | - | - |
| Dec. 31, 2025 | 6.4 million | - | - |
| Sept. 30, 2025 | 4.5 million | - | - |
| June 30, 2025 | 5.2 million | - | - |
GRTX Shares Outstanding
GRTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 15000 | 1.6 million | - |
| Dec. 31, 2025 | - | 42000 | 1.5 million | - |
| Sept. 30, 2025 | - | 130000 | 1.3 million | - |
| June 30, 2025 | - | 84000 | 1.1 million | - |
GRTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | - |
GRTX
Price: $0.09
52 week price:
Earnings Per Share: 0.64 USD
P/E Ratio: 0.16
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 52746
Market Capitalization: 7.6 million